Paving the way for targeting RSK in cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.1, 2011-01, pp. : 5-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The promise and challenges of targeting RSK for the treatment of cancer

By Stratford Anna L Dunn Sandra E

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

Targeting RSK2 in human malignancies

By Kang Sumin Chen Jing

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite

Paving the way for pharmacist prescribing in Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Editorial: Paving the Way for Improved Antiplatelet Therapy (Hot Topic : New Perspectives in Antiplatelet Therapy)

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5195-5196

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy in Breast Cancer- Paving New Roads?

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-09 ,pp. : 208-216

Bentham Science Publishers

Access to resources Recommend Favorite